NOVARTIS AG Annual Research And Development Expense in USD from 2015 to 2024

Taxonomy & unit
ifrs-full: USD
Summary
Novartis Ag annual/quarterly Research And Development Expense history and growth rate from 2015 to 2024.
  • Novartis Ag Research And Development Expense for the quarter ending June 30, 2024 was $2.37B, a 2.73% increase year-over-year.
  • Novartis Ag annual Research And Development Expense for 2024 was $10B, a 11.9% decline from 2023.
  • Novartis Ag annual Research And Development Expense for 2023 was $11.4B, a 24% increase from 2022.
  • Novartis Ag annual Research And Development Expense for 2022 was $9.17B, a 6.15% increase from 2021.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10B -$1.35B -11.9% Jan 1, 2024 Dec 31, 2024 20-F 2025-01-31
2023 $11.4B +$2.2B +24% Jan 1, 2023 Dec 31, 2023 20-F 2025-01-31
2022 $9.17B +$531M +6.15% Jan 1, 2022 Dec 31, 2022 20-F 2025-01-31
2021 $8.64B -$339M -3.78% Jan 1, 2021 Dec 31, 2021 20-F 2024-01-31
2020 $8.98B -$422M -4.49% Jan 1, 2020 Dec 31, 2020 20-F/A 2023-05-15
2019 $9.4B +$913M +10.8% Jan 1, 2019 Dec 31, 2019 20-F 2022-02-02
2018 $8.49B +$100M +1.19% Jan 1, 2018 Dec 31, 2018 20-F 2021-01-26
2017 $8.39B -$650M -7.19% Jan 1, 2017 Dec 31, 2017 20-F 2020-01-29
2016 $9.04B +$104M +1.16% Jan 1, 2016 Dec 31, 2016 20-F 2019-01-30
2015 $8.94B Jan 1, 2015 Dec 31, 2015 6-K 2018-01-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.